Drug News
-
Top 20 Largest Pharmaceutical Companies by Revenue
The pharmaceutical industry is a global powerhouse, with some companies reaching staggering revenue figures as they drive medical advancements and…
Read More » -
FDA Expands Access to IV and PD Solutions Following Hurricane Helene Disruptions
In response to supply disruptions caused by Hurricane Helene’s damage to Baxter International Inc.’s North Cove facility in Marion, North…
Read More » -
How Automatic Pharmacy Dispensers Work: Revolutionizing Medication Safety and Efficiency
The healthcare industry has witnessed significant advancements in technology over the years, with one of the most remarkable innovations being…
Read More » -
Study Links Wegovy and Ozempic to Sight-Threatening Eye Disorder
A recent study has highlighted a concerning potential side effect of semaglutide, the active ingredient in Novo Nordisk’s popular weight-loss…
Read More » -
Glenmark Pharmaceuticals Recalls Potassium Chloride Extended-Release Capsules Due to Failed Dissolution
Glenmark Pharmaceuticals Inc., USA, based in Mahwah, NJ, has announced a voluntary recall of 114 batches of their Potassium Chloride…
Read More » -
Diabetes Test Less Reliable In Black Patients
The discovery of a genetic variation common among people of African ancestry, known as G6PD deficiency (G6PDdef), has significant implications…
Read More » -
Chinese Police Probe Drug-Related Money Laundering Operation After U.S. Tip
Chinese police are investigating a case of illegal foreign exchange activity and money laundering following tip-offs from the United States,…
Read More » -
Roche Partners with Ascidian Therapeutics to Develop Gene Therapies
June 18, 2024 – Swiss pharmaceutical giant Roche has announced a partnership with Boston-based biotech startup Ascidian Therapeutics to develop…
Read More » -
FDA Approves Merck’s New Pneumococcal Vaccine for Adults
June 18, 2024 – The U.S. Food and Drug Administration (FDA) has approved Merck & Co Inc’s latest pneumococcal vaccine,…
Read More » -
FDA Places Zentalis’ Cancer Drug Studies on Partial Hold After Patient Deaths
June 18, 2024 – The U.S. Food and Drug Administration (FDA) has placed three studies of Zentalis Pharmaceuticals’ cancer drug,…
Read More »
